Kan. Admin. Regs. § 28-21-268

Current through Register Vol. 43, No. 46, November 14, 2024

Section 28-21-268 - Price and fee control

(a) The maximum reasonable price at which amygdalin (laetrile) may be sold to a pharmacist or direct to a physician licensed in the state of Kansas shall be based on cost of production for the product plus 25% (twenty-five percent). A cost of production analysis report which has been approved by a certified public accountant shall be submitted to the secretary of health and environment prior to establishment of the wholesale cost of the product.

(b) No increase over and above the wholesale or retail cost of amygdalin (laetrile) may be made by a physician who administers or prescribes this product. The physician may charge a fee only for his professional services in prescribing or administering amygdalin (laetrile).

Authorized by K.S.A. 1978 Supp. 65-6b06, 65-6b07; effective May 1, 1979.